Nyxoah SA Logo

Nyxoah SA (5YI)

FSX

Currency in EUR
1.07
-0.02 (-2.01%)

Closed

Oct 9, 2026

Day's Range

1.07
1.18

52 wk Range

0.9120
6.04

Overview - 5YI - Nyxoah SA

Key Statistics

Valuation

Enterprise Value

67.47M

P/E (Trailing)

‪-0.44‬

P/E (Forward)

‪-0.73‬

PEG Ratio

‪-0.09‬

Price / Sales (TTM)

‪4.94‬

Price / Book

‪1.26‬

EV / EBITDA

‪-0.81‬

Profitability

Gross Margin

‪59.72%‬

Profit Margin

‪63.13%‬

Operating Margin

‪-268.24%‬

Return on Assets

‪-36.86%‬

Return on Equity

‪-122.68%‬

Ownership

Shares Outstanding

100.07M

Float

50.88M

Held by Insiders

‪33.19%‬

Held by Institutions

‪29.90%‬

Price stats

Beta

‪0.96‬

50-Day Avg

‪1.22‬

200-Day Avg

‪2.40‬

Dividends

Payout Ratio

‪0.00%‬

News Teaser - 5YI - Nyxoah SA

News & Analysis

View all news

Market Cap - 5YI - Nyxoah SA

Peers - 5YI - Nyxoah SA

Peer Comparison

Compared with companies in Medical Instruments & Supplies listed on FSX.

Profile Summary - 5YI - Nyxoah SA

About

Nyxoah SA is a medical technology company focused on developing and commercializing solutions for obstructive sleep apnea, a common sleep-disordered breathing condition. Nyxoah’s lead product is the Genio system, a patient-centered hypoglossal neurostimulation therapy designed to help treat moderate to severe…

SectorHealthcare
IndustryMedical Instruments & Supplies
Employees183
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.